Pascal Biosciences Inc.
OTC: PSCBF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John Kueber
- Employees
- 2
- Headquarters
- Seattle, United States
- IPO year
- 2015
- Market cap
- $4.2M
- Website
- https://www.pascalbiosciences.com
Loading PSCBF…
Loading profile data…Frequently asked questions about PSCBF
What does Pascal Biosciences Inc. (PSCBF) do?
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glio...
Where does PSCBF trade?
Pascal Biosciences Inc. (PSCBF) trades on the Other OTC.
What sector is PSCBF in?
Pascal Biosciences Inc. (PSCBF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pascal Biosciences Inc.?
John Kueber is the chief executive officer of Pascal Biosciences Inc. (PSCBF).
Where is Pascal Biosciences Inc. headquartered?
Pascal Biosciences Inc. is headquartered in United States.
Does PSCBF pay a dividend?
Pascal Biosciences Inc. (PSCBF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PSCBF go public?
Pascal Biosciences Inc. (PSCBF) completed its initial public offering in 2015.